Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Transplant Experts Urge Caution As CMS Weighs Expanded LVAD Coverage

This article was originally published in The Gray Sheet

Executive Summary

Groups representing artificial heart transplant providers and researchers are advising CMS to make sure there is adequate clinical evidence before the agency expands Medicare coverage for left ventricular assist devices as a destination therapy for New York Heart Association Class IIIB patients
Advertisement

Related Content

Thoratec Unloads Dx Equipment Unit To Danaher To Help Fund VAD Efforts
Thoratec Unloads Dx Equipment Unit To Danaher To Help Fund VAD Efforts
Medicare In Brief
Medicare In Brief

Topics

Advertisement
UsernamePublicRestriction

Register

MT028682

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel